Energenesis Biomedical CO.,LTD. (6657.TW)

TWD 57.2

(-5.61%)

Gross Profit Summary of Energenesis Biomedical CO.,LTD.

  • Energenesis Biomedical CO.,LTD.'s latest annual gross profit in 2023 was 5.22 Million TWD , up 1.2% from previous year.
  • Energenesis Biomedical CO.,LTD.'s latest quarterly gross profit in 2024 Q2 was 1.22 Million TWD , up 11.22% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported a annual gross profit of 5.16 Million TWD in annual gross profit 2022, down -3.62% from previous year.
  • Energenesis Biomedical CO.,LTD. reported a annual gross profit of 5.35 Million TWD in annual gross profit 2021, up 11.07% from previous year.
  • Energenesis Biomedical CO.,LTD. reported a quarterly gross profit of 1.1 Million TWD for 2024 Q1, down -32.87% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported a quarterly gross profit of 1.23 Million TWD for 2023 Q1, down -26.95% from previous quarter.

Annual Gross Profit Chart of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Historical Annual Gross Profit of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 5.22 Million TWD 1.2%
2022 5.16 Million TWD -3.62%
2021 5.35 Million TWD 11.07%
2020 4.82 Million TWD 24.71%
2019 3.86 Million TWD 0.0%

Peer Gross Profit Comparison of Energenesis Biomedical CO.,LTD.

Name Gross Profit Gross Profit Difference
Apex Biotechnology Corp. 531.11 Million TWD 99.016%
Sinphar Pharmaceutical Co.,Ltd. 1.09 Billion TWD 99.521%
Panion & Bf Biotech Inc. 912.56 Million TWD 99.427%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 757.3 Million TWD 99.31%
GenMont Biotech Incorporation 177.33 Million TWD 97.052%
Abnova (Taiwan) Corporation 173.91 Million TWD 96.995%
Adimmune Corporation 410.93 Million TWD 98.728%
Tanvex BioPharma, Inc. 59.7 Million TWD 91.245%
Polaris Group -137.9 Million TWD 103.79%
UnicoCell Biomed Co., Ltd. 17.89 Million TWD 70.794%
PELL Bio-Med Technology Co. Ltd. -26.14 Million TWD 119.996%